Skip to main content

Advertisement

SpringerLink
Log in

Incidence of venous thromboembolism and predictive ability of age-adjusted international prognostic index for prediction of venous thromboembolism in Asian patients with diffuse large B-cell lymphoma

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Diffuse large B-cell lymphoma (DLBCL) is one of the malignancies at high risk for the development of venous thromboembolism (VTE). We aimed to evaluate the incidence of VTE and the predictive ability of the age-adjusted international prognostic index (aaIPI) for the prediction of VTE among DLBCL patients. This was a retrospective cohort study including adult patients with newly diagnosed DLBCL. Differences in VTE occurrence within one year after diagnosis of DLBCL were estimated across aaIPI groups using the Kaplan-Meier model, Cox’s model, and Gray’s model with deaths regarded as competing events. Five hundred and ninety-one newly diagnosed DLBCL patients with a median age of 58 (range 16–93) years were included in this study. At a median follow-up time of 365 (range 2-365) days, VTE events were objectively diagnosed in 32 patients, giving a one-year cumulative incidence of VTE of 5.4% (95% confidence interval [CI], 3.7–7.6). Patients with aaIPI ≥ 2 had a significantly higher risk of VTE than patients with aaIPI < 2 (hazard ratio, 3.5; 95% CI, 1.6–7.8; p = 0.001 based on Cox’s model and sub-distribution hazard ratio, 3.0; 95% CI, 1.3–6.7; p = 0.007 using Gray’s model). The C-statistic of aaIPI was 0.65 (95% CI, 0.58–0.72). We demonstrated that the incidence of VTE in Asian DLBCL patients was not uncommon. The aaIPI was effective in determining the risk of VTE in DLBCL patients, even when including death as a competing event. aaIPI may be helpful in identifying patients at higher risk of VTE in DLBCL patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Chew HK, Wun T, Harvey D, Zhou H, White RH (2006) Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 166(4):458–464. https://doi.org/10.1001/archinte.166.4.458

    Article  PubMed  Google Scholar 

  2. Moik F, Ay C, Pabinger I (2020) Risk prediction for cancer-associated Thrombosis in ambulatory patients with cancer: past, present and future. Thromb Res 191:S3–S11. https://doi.org/10.1016/s0049-3848(20)30389-3

    Article  CAS  PubMed  Google Scholar 

  3. Syrigos K, Grapsa D, Sangare R, Evmorfiadis I, Larsen AK, Van Dreden P et al (2018) Prospective Assessment of clinical risk factors and biomarkers of hypercoagulability for the identification of patients with lung adenocarcinoma at risk for Cancer-Associated Thrombosis: the observational ROADMAP-CAT study. Oncologist 23(11):1372–1381. https://doi.org/10.1634/theoncologist.2017-0530

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Norris LA, Ward MP, O’Toole SA, Marchocki Z, Ibrahim N, Khashan AS et al (2020) A risk score for prediction of venous thromboembolism in gynecologic cancer: the Thrombogyn score. Res Pract Thromb Haemost 4(5):848–859. https://doi.org/10.1002/rth2.12342

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Rupa-Matysek J, Brzezniakiewicz-Janus K, Gil L, Krasinski Z, Komarnicki M (2018) Evaluation of the ThroLy score for the prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies in clinical practice. Cancer Med 7(7):2868–2875. https://doi.org/10.1002/cam4.1540

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Covut F, Ahmed R, Chawla S, Ricaurte F, Samaras CJ, Anwer F et al (2021) Validation of the IMPEDE VTE score for prediction of venous thromboembolism in Multiple Myeloma: a retrospective cohort study. Br J Haematol 193(6):1213–1219. https://doi.org/10.1111/bjh.17505

    Article  CAS  PubMed  Google Scholar 

  7. Lee LH, Gallus A, Jindal R, Wang C, Wu CC (2017) Incidence of venous thromboembolism in Asian populations: a systematic review. Thromb Haemost 117(12):2243–2260. https://doi.org/10.1160/TH17-02-0134

    Article  PubMed  Google Scholar 

  8. Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW (2008) Development and validation of a predictive model for chemotherapy-associated Thrombosis. Blood 111(10):4902–4907. https://doi.org/10.1182/blood-2007-10-116327

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Akasaka-Kihara F, Sueta D, Ishii M, Maki Y, Hirakawa K, Tabata N et al (2021) Validation of the Khorana venous thromboembolism risk score in Japanese Cancer patients. JACC: Asia 1(2):259–270. https://doi.org/10.1016/j.jacasi.2021.07.006

    Article  PubMed  PubMed Central  Google Scholar 

  10. Mahajan A, Wun T, Chew H, White RH (2014) Lymphoma and venous thromboembolism: influence on mortality. Thromb Res. https://doi.org/10.1016/s0049-3848(14)50004-7

    Article  PubMed  Google Scholar 

  11. Muller AM, Ihorst G, Mertelsmann R, Engelhardt M (2005) Epidemiology of non-hodgkin’s Lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 84(1):1–12. https://doi.org/10.1007/s00277-004-0939-7

    Article  PubMed  Google Scholar 

  12. Dharmavaram G, Cao S, Sundaram S, Ayyappan S, Boughan K, Gallogly M et al (2020) Aggressive Lymphoma subtype is a risk factor for venous Thrombosis. Development of Lymphoma - specific venous Thrombosis prediction models. Am J Hematol 95(8):918–926. https://doi.org/10.1002/ajh.25837

    Article  CAS  PubMed  Google Scholar 

  13. Komrokji RS, Uppal NP, Khorana AA, Lyman GH, Kaplan KL, Fisher RI et al (2006) Venous thromboembolism in patients with diffuse large B-cell Lymphoma. Leuk Lymphoma 47(6):1029–1033. https://doi.org/10.1080/10428190600560991

    Article  PubMed  Google Scholar 

  14. International Non-hodgkin’s Lymphoma Prosgnostic Factors Project (1993) A predictive model for aggressive non-hodgkin’s Lymphoma. N Engl J Med 329(14):987–994. https://doi.org/10.1056/NEJM199309303291402

    Article  Google Scholar 

  15. Young AM, Marshall A, Thirlwall J, Chapman O, Lokare A, Hill C et al (2018) Comparison of an oral factor xa inhibitor with low Molecular Weight Heparin in patients with Cancer with venous thromboembolism: results of a Randomized Trial (SELECT-D). J Clin Oncol 36(20):2017–2023. https://doi.org/10.1200/JCO.2018.78.8034

    Article  CAS  PubMed  Google Scholar 

  16. Agnelli G, Becattini C, Meyer G, Munoz A, Huisman MV, Connors JM et al (2020) Apixaban for the treatment of venous Thromboembolism Associated with Cancer. N Engl J Med 382(17):1599–1607. https://doi.org/10.1056/NEJMoa1915103

    Article  CAS  PubMed  Google Scholar 

  17. Raskob GE, van Es N, Verhamme P, Carrier M, Di Nisio M, Garcia D et al (2018) Edoxaban for the treatment of Cancer-Associated venous thromboembolism. N Engl J Med 378(7):615–624. https://doi.org/10.1056/NEJMoa1711948

    Article  CAS  PubMed  Google Scholar 

  18. Caruso V, Di Castelnuovo A, Meschengieser S, Lazzari MA, de Gaetano G, Storti S et al (2010) Thrombotic Complications in adult patients with Lymphoma: a meta-analysis of 29 Independent cohorts including 18 018 patients and 1149 events. Blood 115(26):5322–5328. https://doi.org/10.1182/blood-2010-01-258624

    Article  CAS  PubMed  Google Scholar 

  19. Uno H, Cai T, Pencina MJ, D’Agostino RB, Wei LJ (2011) On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Stat Med 30(10):1105–1117. https://doi.org/10.1002/sim.4154

    Article  PubMed  PubMed Central  Google Scholar 

  20. Harrell FE Jr, Lee KL, Califf RM, Pryor DB, Rosati RA (1984) Regression modelling strategies for improved prognostic prediction. Stat Med 3(2):143–152. https://doi.org/10.1002/sim.4780030207

    Article  PubMed  Google Scholar 

  21. Chen Y, Lei H, Wang W, Zhu J, Zeng C, Lu Z et al (2022) Characteristics and predictors of venous thromboembolism among Lymphoma patients undergoing chemotherapy: a Cohort Study in China. Front Pharmacol 13:901887. https://doi.org/10.3389/fphar.2022.901887

    Article  PubMed  PubMed Central  Google Scholar 

  22. Park LC, Woo SY, Kim S, Jeon H, Ko YH, Kim SJ et al (2012) Incidence, risk factors and clinical features of venous thromboembolism in newly diagnosed Lymphoma patients: results from a prospective cohort study with Asian population. Thromb Res 130(3):e6–12. https://doi.org/10.1016/j.thromres.2012.03.019

    Article  CAS  PubMed  Google Scholar 

  23. Yokoyama K, Murata M, Ikeda Y, Okamoto S (2012) Incidence and risk factors for developing venous thromboembolism in Japanese with diffuse large b-cell Lymphoma. Thromb Res 130(1):7–11. https://doi.org/10.1016/j.thromres.2011.09.022

    Article  CAS  PubMed  Google Scholar 

  24. Mohren M, Markmann I, Jentsch-Ullrich K, Koenigsmann M, Lutze G, Franke A (2005) Increased risk of thromboembolism in patients with malignant Lymphoma: a single-centre analysis. Br J Cancer 92(8):1349–1351. https://doi.org/10.1038/sj.bjc.6602504

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Lee LH, Nagarajan C, Tan CW, Ng HJ (2021) Epidemiology of Cancer-Associated Thrombosis in Asia: a systematic review. Front Cardiovasc Med 8:669288. https://doi.org/10.3389/fcvm.2021.669288

    Article  PubMed  PubMed Central  Google Scholar 

  26. Abdel-Razeq H, Ma’koseh M, Abdel-Razeq R, Amarin R, Abufara A, Mansour R et al (2021) The application of the Lymphoma International Prognostic Index to predict venous thromboembolic events in diffuse large B-Cell Lymphoma patients. Front Oncol 11:677776. https://doi.org/10.3389/fonc.2021.677776

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Lyman GH, Eckert L, Wang Y, Wang H, Cohen A (2013) Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real-world analysis. Oncologist 18(12):1321–1329. https://doi.org/10.1634/theoncologist.2013-0226

    Article  PubMed  PubMed Central  Google Scholar 

  28. Lim SH, Woo SY, Kim S, Ko YH, Kim WS, Kim SJ (2016) Cross-sectional study of patients with diffuse large B-Cell Lymphoma: assessing the effect of host status, Tumor Burden, and inflammatory activity on venous thromboembolism. Cancer Res Treat 48(1):312–321. https://doi.org/10.4143/crt.2014.266

    Article  CAS  PubMed  Google Scholar 

  29. Rupa-Matysek J, Gil L, Kazmierczak M, Baranska M, Komarnicki M (2017) Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana risk score. Med Oncol 35(1):5. https://doi.org/10.1007/s12032-017-1065-4

    Article  PubMed  PubMed Central  Google Scholar 

  30. Borg IH, Bendtsen MD, Bogsted M, Madsen J, Severinsen MT (2016) Incidence of venous thromboembolism in patients with diffuse large B-cell Lymphoma. Leuk Lymphoma 57(12):2771–2776. https://doi.org/10.1080/10428194.2016.1185782

    Article  CAS  PubMed  Google Scholar 

  31. Carrier M, Abou-Nassar K, Mallick R, Tagalakis V, Shivakumar S, Schattner A et al (2019) Apixaban to prevent venous thromboembolism in patients with Cancer. N Engl J Med 380(8):711–719. https://doi.org/10.1056/NEJMoa1814468

    Article  CAS  PubMed  Google Scholar 

  32. Khorana AA, Soff GA, Kakkar AK, Vadhan-Raj S, Riess H, Wun T et al (2019) Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory patients with Cancer. N Engl J Med 380(8):720–728. https://doi.org/10.1056/NEJMoa1814630

    Article  CAS  PubMed  Google Scholar 

  33. Mulder FI, Candeloro M, Kamphuisen PW, Di Nisio M, Bossuyt PM, Guman N et al (2019) The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis. Haematologica 104(6):1277–1287. https://doi.org/10.3324/haematol.2018.209114

    Article  PubMed  PubMed Central  Google Scholar 

  34. Ay C, Simanek R, Vormittag R, Dunkler D, Alguel G, Koder S et al (2008) High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis study (CATS). Blood 112(7):2703–2708. https://doi.org/10.1182/blood-2008-02-142422

    Article  CAS  PubMed  Google Scholar 

  35. Khorana AA, Francis CW, Menzies KE, Wang JG, Hyrien O, Hathcock J et al (2008) Plasma tissue factor may be predictive of venous thromboembolism in Pancreatic cancer. J Thromb Haemost 6(11):1983–1985. https://doi.org/10.1111/j.1538-7836.2008.03156.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Vormittag R, Simanek R, Ay C, Dunkler D, Quehenberger P, Marosi C et al (2009) High factor VIII levels independently predict venous thromboembolism in Cancer patients. Arterioscler Thromb Vasc Biol 29(12):2176–2181. https://doi.org/10.1161/atvbaha.109.190827

    Article  CAS  PubMed  Google Scholar 

  37. Reitter EM, Ay C, Kaider A, Pirker R, Zielinski C, Zlabinger G et al (2014) Interleukin levels and their potential association with venous thromboembolism and survival in cancer patients. Clin Exp Immunol 177(1):253–260. https://doi.org/10.1111/cei.12308

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Antic D, Milic N, Nikolovski S, Todorovic M, Bila J, Djurdjevic P et al (2016) Development and validation of multivariable predictive model for thromboembolic events in Lymphoma patients. Am J Hematol 91(10):1014–1019. https://doi.org/10.1002/ajh.24466

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

    Nonthakorn Hantrakun, Adisak Tantiworawit, Ekarat Rattarittamrong, Chatree Chai-Adisaksopha, Thanawat Rattanathammethee, Sasinee Hantrakool, Pokpong Piriyakhuntorn, Teerachat Punnachet, Piangrawee Niprapan & Lalita Norasetthada

  2. Department of Family Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

    Phichayut Phinyo

  3. Center for Clinical Epidemiology and Clinical Statistic, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

    Phichayut Phinyo

Authors
  1. Nonthakorn Hantrakun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Phichayut Phinyo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Adisak Tantiworawit
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ekarat Rattarittamrong
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chatree Chai-Adisaksopha
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Thanawat Rattanathammethee
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sasinee Hantrakool
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Pokpong Piriyakhuntorn
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Teerachat Punnachet
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Piangrawee Niprapan
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Lalita Norasetthada
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lalita Norasetthada.

Ethics declarations

Conflict of interest

There is no conflict of interest to disclose in relation to this study.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 16 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hantrakun, N., Phinyo, P., Tantiworawit, A. et al. Incidence of venous thromboembolism and predictive ability of age-adjusted international prognostic index for prediction of venous thromboembolism in Asian patients with diffuse large B-cell lymphoma. J Thromb Thrombolysis 57, 473–482 (2024). https://doi.org/10.1007/s11239-023-02908-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-023-02908-5

Keywords

Search

Navigation